NIH Extramural Clinical Research: Internal Controls Are Key to Safeguarding Phase III Trials Against Misconduct
HEHS-96-117
Published: Jul 11, 1996. Publicly Released: Jul 11, 1996.
Skip to Highlights
Highlights
Pursuant to a congressional request, GAO reviewed the National Institutes of Health's (NIH) oversight of the clinical trials it sponsors, focusing on NIH internal controls to prevent misuse of federal funds and safeguard the integrity of clinical trial data.
Full Report
Office of Public Affairs
Topics
Cancer researchData integrityEthical conductFederal fundsFinancial managementHealth research programsInternal controlsMedical researchResearch grantsResearch program management